• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢癌患者二次剖腹探查术前CA 125检测的价值。

The value of CA 125 measurement before second-look laparotomy in patients with ovarian carcinoma.

作者信息

Hørding U, Toftager-Larsen K, Lund B, Dreisler A, Daugaard S, Lundvall F, Knudsen J B, Bock J E

机构信息

Finsen Institute, Rigshospitalet, University Hospital, Copenhagen.

出版信息

Eur J Gynaecol Oncol. 1994;15(3):217-21.

PMID:7957327
Abstract

Serum CA 125 levels were evaluated in 71 patients undergoing second-look laparotomy for primary epithelial ovarian cancer. With a cut-off limit of 35 U/ml, 17 of 45 patients with residual disease (38%) were CA 125-positive. All of 26 patients with pathological complete response were marker-negative. Second-look laparotomy may be avoided in a select group of patients with elevated CA 125 values.

摘要

对71例接受原发性上皮性卵巢癌二次剖腹探查术的患者进行了血清CA 125水平评估。以35 U/ml为临界值,45例有残留病灶的患者中有17例(38%)CA 125呈阳性。26例病理完全缓解的患者均为标志物阴性。对于CA 125值升高的特定患者群体,可避免进行二次剖腹探查术。

相似文献

1
The value of CA 125 measurement before second-look laparotomy in patients with ovarian carcinoma.卵巢癌患者二次剖腹探查术前CA 125检测的价值。
Eur J Gynaecol Oncol. 1994;15(3):217-21.
2
Predictive value of the combined serum CA 125 and TPS during chemotherapy and before second-look laparotomy in epithelial ovarian cancer.上皮性卵巢癌化疗期间及二次剖腹探查术前联合检测血清CA 125和TPS的预测价值
Anticancer Res. 2000 Mar-Apr;20(2B):1297-300.
3
The role of second-look laparotomy in treatment of epithelial ovarian cancer.二次剖腹探查术在上皮性卵巢癌治疗中的作用。
Gynecol Oncol. 1987 Sep;28(1):83-8. doi: 10.1016/s0090-8258(87)80012-4.
4
Predictive and prognostic values of cancer-associated serum antigen (CASA) and cancer antigen 125 (CA 125) levels prior to second-look laparotomy for ovarian cancer.
Gynecol Oncol. 1995 Nov;59(2):251-4. doi: 10.1006/gyno.1995.0017.
5
[The value of cytoreductive second-look surgery in advanced epithelial ovarian carcinoma].[减瘤性二次探查手术在晚期上皮性卵巢癌中的价值]
Wien Klin Wochenschr. 1990 Aug 3;102(15):441-3.
6
Current management of epithelial ovarian carcinoma: a review.上皮性卵巢癌的当前管理:综述
Semin Surg Oncol. 2000 Jul-Aug;19(1):11-9. doi: 10.1002/1098-2388(200007/08)19:1<11::aid-ssu3>3.0.co;2-3.
7
Place of second-look laparotomy after 18 courses of chemotherapy in epithelial ovarian cancer.上皮性卵巢癌在接受18个疗程化疗后的二次剖腹探查部位。
Aust N Z J Obstet Gynaecol. 1989 Feb;29(1):52-4. doi: 10.1111/j.1479-828x.1989.tb02877.x.
8
Monitoring cancer antigen 125 levels in induction chemotherapy for epithelial ovarian carcinoma and predicting outcome of second-look procedure.监测上皮性卵巢癌诱导化疗过程中癌抗原125水平并预测二次探查手术的结果
Gynecol Oncol. 1995 May;57(2):178-82. doi: 10.1006/gyno.1995.1121.
9
Negative second-look laparotomy does not preclude recurrence in stage I ovarian carcinoma of any histological variety.阴性二次剖腹探查术并不能排除任何组织学类型的Ⅰ期卵巢癌复发。
Eur J Gynaecol Oncol. 1993;14(1):36-9.
10
Serum half-life of CA 125 during early chemotherapy as an independent prognostic variable for patients with advanced epithelial ovarian cancer: results of a multicentric Italian study.早期化疗期间CA 125的血清半衰期作为晚期上皮性卵巢癌患者的独立预后变量:一项意大利多中心研究的结果
Gynecol Oncol. 1995 Jul;58(1):42-7. doi: 10.1006/gyno.1995.1181.